CUFinder

Jianning Ge

Jianning Ge

University of Southern California

H-index: 14

North America-United States

Contact Jianning Ge

About Jianning Ge

Jianning Ge, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at University of Southern California, specializes in the field of Immunology, Microbiology, Virology, Biochemistry, Molecular Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism

Abstract CT196: Early results of a safety and efficacy study of allogeneic TruUCAR™ GC502 in patients with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Preclinical results of an allogeneic, universal CD19/CD7-targeting CAR-T cell therapy (GC502) for B cell malignancies

Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic …

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).

Jianning Ge Information

University

Position

Keck School of Medicine

Citations(all)

2038

Citations(since 2020)

1108

Cited By

1424

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Jianning Ge Skills & Research Interests

Immunology

Microbiology

Virology

Biochemistry

Molecular Biology

Top articles of Jianning Ge

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism

Plos one

2024/2/8

Jianning Ge
Jianning Ge

H-Index: 12

Dokyun Kim
Dokyun Kim

H-Index: 1

Jae Jin Lee
Jae Jin Lee

H-Index: 11

Weiqiang Chen
Weiqiang Chen

H-Index: 23

Hyungjin Eoh
Hyungjin Eoh

H-Index: 17

Abstract CT196: Early results of a safety and efficacy study of allogeneic TruUCAR™ GC502 in patients with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Cancer Research

2022/6/15

Xinxin Wang
Xinxin Wang

H-Index: 1

Lin Liu
Lin Liu

H-Index: 6

Yu Li
Yu Li

H-Index: 11

Jia Liu
Jia Liu

H-Index: 5

Wei Zhao
Wei Zhao

H-Index: 20

Jianning Ge
Jianning Ge

H-Index: 12

Wei Cao
Wei Cao

H-Index: 19

Xi Zhang
Xi Zhang

H-Index: 8

Preclinical results of an allogeneic, universal CD19/CD7-targeting CAR-T cell therapy (GC502) for B cell malignancies

Blood

2021/11/23

Jianning Ge
Jianning Ge

H-Index: 12

Jing Sun
Jing Sun

H-Index: 10

Jiao Chen
Jiao Chen

H-Index: 5

Wenjie Yin
Wenjie Yin

H-Index: 3

Wei Cao
Wei Cao

H-Index: 19

Xinxin Wang
Xinxin Wang

H-Index: 1

Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic …

Cancer Research

2020/8/15

Xinxin Wang
Xinxin Wang

H-Index: 1

Lei Gao
Lei Gao

H-Index: 8

Kun Wu
Kun Wu

H-Index: 1

Lin Liu
Lin Liu

H-Index: 6

Le Luo
Le Luo

H-Index: 12

Yao Liu
Yao Liu

H-Index: 22

Cheng Zhang
Cheng Zhang

H-Index: 4

Jia Liu
Jia Liu

H-Index: 5

Yu Li
Yu Li

H-Index: 11

Xun Ye
Xun Ye

H-Index: 4

Xu Tan
Xu Tan

H-Index: 2

Jianning Ge
Jianning Ge

H-Index: 12

Yu Han
Yu Han

H-Index: 6

Youcheng Wang
Youcheng Wang

H-Index: 14

Wei Cao
Wei Cao

H-Index: 19

Xi Zhang
Xi Zhang

H-Index: 8

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).

2020/5/20

Xinxin Wang
Xinxin Wang

H-Index: 1

Lei Gao
Lei Gao

H-Index: 8

Kun Wu
Kun Wu

H-Index: 1

Lin Liu
Lin Liu

H-Index: 6

Le Luo
Le Luo

H-Index: 12

Yao Liu
Yao Liu

H-Index: 22

Cheng Zhang
Cheng Zhang

H-Index: 4

Jia Liu
Jia Liu

H-Index: 5

Yu Li
Yu Li

H-Index: 11

Xun Ye
Xun Ye

H-Index: 4

Xu Tan
Xu Tan

H-Index: 2

Jianning Ge
Jianning Ge

H-Index: 12

Wei Cao
Wei Cao

H-Index: 19

Xi Zhang
Xi Zhang

H-Index: 8

See List of Professors in Jianning Ge University(University of Southern California)